An employee of the FDA’s Center for Biologics Evaluation and Research says the agency rushed a first-of-its kind medical product to market prematurely.
https://www.theepochtimes.com/us/whistleblower-alleges-fda-approved-medical-product-despite-experts-concerns-5827049
